Board of Advisors

LSC    San Diego    Join 

Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Annually, our Advisors make a personal financial contribution to cover LSC’s administrative costs, allowing us to channel money raised from our event fundraisers, Corporate Membership Program, and from individuals to our partner organizations.

Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort. For more information on how to join our Board of Advisors please email


Chuck  Baum

Chuck Baum

President and Chief Executive Officer

Mirati Therapeutics

Daniel Benson

Daniel Benson


Tyra Biosciences

Dan Burgess

Dan Burgess

Venture Partner

SV Health Investors

James  Burns

James Burns

Chief Executive Officer

Locana bio

Jennifer  Cayer

Jennifer Cayer

Board Chair

Moores UCSD Cancer Center Board

Jacob Chacko

Jacob Chacko


ORIC Pharmaceuticals

Isan  Chen M.D.

Isan Chen M.D.

President & CEO

MBrace Therapeutics, Inc.

Michael  Dudley

Michael Dudley

President and Chief Executive Officer


David  Duenas

David Duenas

EVP of Consulting/ Life Sciences and Strategic Accounts Practice Leader

Hub Insurance Services Inc.

David  Kabakoff

David Kabakoff

Executive Partner Private Equity

SOFINNOVA Investments

Craig Knox

Craig Knox

Senior Vice President

Hughes Marino

Cathy  Lee

Cathy Lee

EVP, General Counsel and Corporate Secretary


Trisha Millican

Trisha Millican

Chief Financial Officer

Metacrine, Inc.

Chrysa  Mineo

Chrysa Mineo


Cidara Therapeutics

Bill Rastetter

Bill Rastetter



Daniel  Ryan

Daniel Ryan

Co-Chief Investment Officer & Regional Market DirectorSan Diego Alexandria Real Estate Equities

San Diego Alexandria Real Estate Equities

Linda  Sierra

Linda Sierra

SVP, Business Development

Bench International

Mike  Tilton

Mike Tilton

Chief Commercial Officer

Avanir Pharmaceuticals

Troy  Wilson

Troy Wilson

Chief Executive Officer and Co-Founder

Kura Oncology